FIELD: pharmaceutics.
SUBSTANCE: present invention relates to novel selective Janus kinase 1 (JAK1) inhibitors, methods of producing said inhibitors, a pharmaceutical composition containing said inhibitors and use thereof.
EFFECT: development of new compounds as selective JAK1 inhibitors.
10 cl, 2 dwg, 4 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HETEROCYCLIC SUBSTANCES-GPR119 AGONISTS | 2017 |
|
RU2734500C2 |
| 2-OXA-5-AZABICYCLO[2.2.1]HEPTANE-3-YL DERIVATIVES | 2015 |
|
RU2697651C2 |
| INDAZOLIE WNT SIGNAL PATHWAY INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS | 2017 |
|
RU2682245C1 |
| INDASOLE INHIBITORS OF Wnt SIGNAL PATH AND THEIR THERAPEUTIC APPLICATIONS | 2013 |
|
RU2638932C2 |
| THIAZOLOPYRIDINE DERIVATIVES AS GPR119 AGONISTS | 2017 |
|
RU2749111C2 |
| KINASE INHIBITORS | 2005 |
|
RU2348635C2 |
| 1H-PYRAZOLO[3,4-B]PYRIDINES AND THEIR THERAPEUTIC APPLICATIONS | 2013 |
|
RU2689141C2 |
| BICYCLIC LACTAMS AND METHODS OF USE THEREOF | 2016 |
|
RU2827714C1 |
| ANALOGUES OF 4H-PYRAZOLO[1,5-A]BENZIMIDAZOLE COMPOUNDS AS PARP INHIBITORS | 2015 |
|
RU2672722C2 |
| NEW ANTITHROMBOTIC AGENT | 2010 |
|
RU2570426C2 |
